These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23229639)

  • 1. Biophysical and structural investigation of bacterially expressed and engineered CCR5, a G protein-coupled receptor.
    Wiktor M; Morin S; Sass HJ; Kebbel F; Grzesiek S
    J Biomol NMR; 2013 Jan; 55(1):79-95. PubMed ID: 23229639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-level production, solubilization and purification of synthetic human GPCR chemokine receptors CCR5, CCR3, CXCR4 and CX3CR1.
    Ren H; Yu D; Ge B; Cook B; Xu Z; Zhang S
    PLoS One; 2009; 4(2):e4509. PubMed ID: 19223978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of intermolecular transferred-NOE interactions in small and medium size protein complexes: RANTES complexed with a CCR5 N-terminal peptide.
    Abayev M; Srivastava G; Arshava B; Naider F; Anglister J
    FEBS J; 2017 Feb; 284(4):586-601. PubMed ID: 28052516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMR mapping of RANTES surfaces interacting with CCR5 using linked extracellular domains.
    Schnur E; Kessler N; Zherdev Y; Noah E; Scherf T; Ding FX; Rabinovich S; Arshava B; Kurbatska V; Leonciks A; Tsimanis A; Rosen O; Naider F; Anglister J
    FEBS J; 2013 May; 280(9):2068-84. PubMed ID: 23480650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural comparison of monomeric variants of the chemokine MIP-1beta having differing ability to bind the receptor CCR5.
    Kim S; Jao S; Laurence JS; LiWang PJ
    Biochemistry; 2001 Sep; 40(36):10782-91. PubMed ID: 11535053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMR analyses of the interaction between CCR5 and its ligand using functional reconstitution of CCR5 in lipid bilayers.
    Yoshiura C; Kofuku Y; Ueda T; Mase Y; Yokogawa M; Osawa M; Terashima Y; Matsushima K; Shimada I
    J Am Chem Soc; 2010 May; 132(19):6768-77. PubMed ID: 20423099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large-scale expression and purification of the major HIV-1 coreceptor CCR5 and characterization of its interaction with RANTES.
    Nisius L; Rogowski M; Vangelista L; Grzesiek S
    Protein Expr Purif; 2008 Oct; 61(2):155-62. PubMed ID: 18588983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analyzing ligand and small molecule binding activity of solubilized GPCRs using biosensor technology.
    Navratilova I; Dioszegi M; Myszka DG
    Anal Biochem; 2006 Aug; 355(1):132-9. PubMed ID: 16762304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.
    Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC
    J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to the CCR5 inhibitor 5P12-RANTES requires a difficult evolution from CCR5 to CXCR4 coreceptor use.
    Nedellec R; Coetzer M; Lederman MM; Offord RE; Hartley O; Mosier DE
    PLoS One; 2011; 6(7):e22020. PubMed ID: 21760945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the role of the N-loop of MIP-1 beta in CCR5 binding.
    Bondue A; Jao SC; Blanpain C; Parmentier M; LiWang PJ
    Biochemistry; 2002 Nov; 41(46):13548-55. PubMed ID: 12427015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCR5 adopts three homodimeric conformations that control cell surface delivery.
    Jin J; Momboisse F; Boncompain G; Koensgen F; Zhou Z; Cordeiro N; Arenzana-Seisdedos F; Perez F; Lagane B; Kellenberger E; Brelot A
    Sci Signal; 2018 May; 11(529):. PubMed ID: 29739880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for common structural determinants of human immunodeficiency virus type 1 coreceptor activity provided through functional analysis of CCR5/CXCR4 chimeric coreceptors.
    Pontow S; Ratner L
    J Virol; 2001 Dec; 75(23):11503-14. PubMed ID: 11689632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence resonance energy transfer imaging reveals that chemokine-binding modulates heterodimers of CXCR4 and CCR5 receptors.
    Isik N; Hereld D; Jin T
    PLoS One; 2008; 3(10):e3424. PubMed ID: 18923649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplex detection of homo- and heterodimerization of g protein-coupled receptors by proximity biotinylation.
    Steel E; Murray VL; Liu AP
    PLoS One; 2014; 9(4):e93646. PubMed ID: 24691126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in studies of structure, mechanism and antagonists interaction of GPCR co-receptors for HIV.
    Zhong B; Zhen Y; Qin G; Yang H; Jiang H; Chen G; Yu K
    Curr Pharm Biotechnol; 2014; 15(10):938-50. PubMed ID: 25374029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The core domain of chemokines binds CCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle.
    Blanpain C; Doranz BJ; Bondue A; Govaerts C; De Leener A; Vassart G; Doms RW; Proudfoot A; Parmentier M
    J Biol Chem; 2003 Feb; 278(7):5179-87. PubMed ID: 12466283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study on CCR5 analogs and affinity peptides.
    Wu Y; Deng R; Wu W
    Protein Eng Des Sel; 2012 Mar; 25(3):97-105. PubMed ID: 22238429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The B-oligomer of pertussis toxin deactivates CC chemokine receptor 5 and blocks entry of M-tropic HIV-1 strains.
    Alfano M; Schmidtmayerova H; Amella CA; Pushkarsky T; Bukrinsky M
    J Exp Med; 1999 Sep; 190(5):597-605. PubMed ID: 10477545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of ligand-based and receptor-based virtual screening of HIV entry inhibitors for the CXCR4 and CCR5 receptors using 3D ligand shape matching and ligand-receptor docking.
    Pérez-Nueno VI; Ritchie DW; Rabal O; Pascual R; Borrell JI; Teixidó J
    J Chem Inf Model; 2008 Mar; 48(3):509-33. PubMed ID: 18298095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.